65% of longevity clinicians think Bryan Johnson adds value

Our 2024 Longevity Clinics Survey is open with respondents from all over the world: Have you participated yet?

Beyond the beneficial data that our survey shares on diagnostic approaches: imaging, cardio, cognitive screening, etc., and interventions offered: peptides, stem cell therapy, PRP, IV therapies, etc., our current survey is delivering some really fascinating results:

67% pursue CMEs (Continuing Medical Education) in healthy longevity medicine.

21% won’t take on patients with serious existing health conditions.

59% think that longevity practice software tools are OK but need more work.

73% help clients identify or manage their biological vs chronological age, which means 27% do not.

My take on this: If you're a longevity clinician or run a clinic, we need just 15 minutes of your time to answer key questions about client demographics, growth, profitability, and more. Your insights will help shape a clearer picture of the industry.

Here’s the link!

Oh, and the Bryan Johnson question was: Do you think Bryan Johnson contributes to (i.e. creates awareness) or hinders (i.e. subverts proper medicine) the progress of longevity medicine?

Don’t agree? Then do join the survey and contribute your opinion.

We have had some excellent comments from leading professionals in the field, and we want to hear what you have to say – we’re live for another two weeks, so please join the conversation!

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!